{
    "organizations": [],
    "uuid": "bc2c8de00cb37095c24bf8775095935037145159",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-medivir-q4-sales-sharply-lower-ebi/brief-medivir-q4-sales-sharply-lower-ebitda-loss-at-93-mln-sek-idUSFWN1Q40TX",
    "ord_in_thread": 0,
    "title": "BRIEF-Medivir Q4 sales sharply lower, EBITDA loss at 93 mln SEK",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 14 (Reuters) - Medivir:\n* Q4 ‍NET TURNOVER FOR CONTINUING OPERATIONS TOTALED SEK 4.2 MILLION (9.9 M), SEK 4.2 MILLION (7.1 M) OF WHICH COMPRISED Q4‘S ROYALTIES​\n* Q4 ‍LOSS BEFORE INTEREST, TAX, DEPRECIATION AND AMORTIZATION (EBITDA) TOTALED SEK -92.6 MILLION (-125.8 M)​\n* Q4 ‍CASH FLOW FROM OPERATING ACTIVITIES AMOUNTED TO SEK -88.9 MILLION (-71.8)​ Source text for Eikon: Further company coverage: (Stockholm Newsroom)\n ",
    "published": "2018-02-14T19:07:00.000+02:00",
    "crawled": "2018-02-15T20:16:54.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "medivir",
        "q4",
        "turnover",
        "continuing",
        "operation",
        "totaled",
        "sek",
        "million",
        "sek",
        "million",
        "comprised",
        "q4",
        "q4",
        "interest",
        "tax",
        "depreciation",
        "amortization",
        "ebitda",
        "totaled",
        "sek",
        "million",
        "q4",
        "flow",
        "operating",
        "activity",
        "amounted",
        "sek",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "stockholm",
        "newsroom"
    ]
}